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How Specific Should Immunological Memory Be?1
Jose´ A. M. Borghans,2 Andre´ J. Noest, and Rob J. De Boer
Protection against infection hinges on a close interplay between the innate immune system and the adaptive immune system.
Depending on the type and context of a pathogen, the innate system instructs the adaptive immune system to induce an appropriate
immune response. Here, we hypothesize that the adaptive immune system stores these instructions by changing from a naive to
an appropriate memory phenotype. In a secondary immune reaction, memory lymphocytes adhere to their instructed phenotype.
Because cross-reactions with unrelated Ags can be detrimental, such a qualitative form of memory requires a sufficient degree of
specificity of the adaptive immune system. For example, lymphocytes instructed to clear a particular pathogen may cause auto-
immunity when cross-reacting with ignored self molecules. Alternatively, memory cells may induce an immune response of the
wrong mode when cross-reacting with subsequent pathogens. To maximize the likelihood of responding to a wide variety of
pathogens, it is also required that the immune system be sufficiently cross-reactive. By means of a probabilistic model, we show
that these conflicting requirements are met optimally by a highly specific memory lymphocyte repertoire. This explains why the
lymphocyte system that was built on a preserved functional innate immune system has such a high degree of specificity. Our
analysis suggests that 1) memory lymphocytes should be more specific than naive lymphocytes and 2) species with small lym-
phocyte repertoires should be more vulnerable to both infection and autoimmune diseases. The Journal of Immunology, 1999,
163: 569–575.
T here is increasing evidence that the vertebrate innate im-mune system is a homologue of the invertebrate non-clonal immune system and that its evolution preceded the
development of the adaptive immune system (1–7). Interestingly,
the innate immune system was preserved when the adaptive im-
mune system evolved. Innate immunity forms an essential part of
the vertebrate immune system by providing signals for the activa-
tion of the adaptive immune system (3–5, 8, 9). A hallmark of
immune responses is the “second signal” (10) delivered to the
adaptive immune system by innate APC that express the mem-
brane proteins B7.1 and B7.2. In the absence of such costimulatory
signals from the innate system, T cells fail to become fully acti-
vated and instead become anergic (11). The adaptive immune sys-
tem is thus dependent on evolutionarily conserved signals. We
adopt the view that the innate system imposes its evolutionary
knowledge on the lymphocyte system instructing it to mount the
appropriate response (1, 5, 8, 9).
This dependence raises an evolutionary problem. It is often ar-
gued that the adaptive immune system evolved to cope with rap-
idly coevolving pathogens. The clonal distribution of randomly
rearranged lymphocyte receptors renders a high flexibility, en-
abling the adaptive immune system to adapt more quickly to co-
evolving pathogens than the innate immune system can. However,
if an adaptive immune response depends strictly on the innate im-
mune system, then pathogenic evasion of an innate response im-
plies evasion of an adaptive immune response (see also Refs. 2 and
3). Viruses have indeed been shown to interfere with the innate
immune system by producing proteins, e.g., soluble cytokine re-
ceptors or proteins that regulate Ag presentation (12–17), that put
the immune system on the wrong track. Rapidly coevolving patho-
gens thus cannot explain why the adaptive immune system has
evolved its diversity. Here, we hypothesize that the specificity of
the adaptive immune system is used to specifically store the in-
structions given by the innate immune system. Using a probabi-
listic model, we demonstrate that this task is best performed if
memory lymphocytes are highly specific.
Building a “world view”
We adopt the view that the innate immune system provides signals
about the context of antigenic epitopes (1, 3, 5, 8, 9, 18–22). De-
pending on 1) the organ where the epitope is detected (23), 2) the
presence of conserved pathogen-associated molecular patterns (1,
9), and perhaps 3) tissue damage (24), the innate system signals
whether the Ag should be attacked and if so, by which immune
effector mechanisms. We conjecture that the evolutionary infor-
mation provided by the innate system is stored in specific lym-
phocytes by their switch from their naive phenotype to a particular
responsive mode or to a nonresponsive mode. Lymphocytes can
thus use their specificity to build up a world view, to learn which
epitopes are dangerous, which are harmless, and which immune
response is most appropriate (25). They should switch to a tolerant
mode, e.g., to anergy, whenever the innate system provides a
harmless context, so that lymphocytes specific for self peptides,
food Ags, and the intestinal flora can be rendered tolerant (26).
Conversely, in a harmful context, lymphocytes should be in-
structed to mount an appropriate immune response and to enter the
solid tissue (23, 26, 27). All instructed lymphocytes, i.e., not only
conventional memory cells but also, e.g., anergic cells, thus carry
information about the appropriate response for the epitopes they
recognize. In our view, immunological memory should thus also
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be regarded as a qualitative memory of the type of immune re-
sponse to be made. On top of this comes the conventional quan-
titative form of memory in terms of increased precursor
frequencies.
There is good evidence that during a secondary encounter of the
same epitope, lymphocytes recall their appropriate response (28–
30) and no longer wait for instructions from the innate system. An
example, that a qualitative memory may enable lymphocytes to
skip over the innate instructions, is the memory for responsiveness
vs nonresponsiveness in mice transgenic for a lymphocytic cho-
riomeningitis viral (LCMV)3 protein (28). In mice expressing the
LCMV protein on their pancreatic b-cells, LCMV-specific T cells
were neither tolerized nor activated by the LCMV protein. On
infection with LCMV, however, the cells became stimulated and
caused T-cell-mediated diabetes. Apparently, once the LCMV-
specific lymphocytes had seen LCMV in an infectious context,
they were instructed to an aggressive response, which was subse-
quently remembered such that the LCMV protein on the pancreas
was regarded as a harmful Ag. Such an LCMV-specific response
could not be induced by LCMV infection in LCMV-transgenic
mice that had been tolerized with LCMV peptides (30). Thus, non-
responsiveness vs responsiveness is qualitatively remembered by
the immune system.
Another example supporting the concept of a qualitative form of
immunological memory is the immunity against vaccinia virus
(VV). VV is one of many viruses that express proteins interfering
with the innate immune system. It prevents its own presentation on
MHC molecules of infected cells, blocks the complement cascade
and several cytokines, and neutralizes chemokines in the local en-
vironment (17). Tackling the immune system at its innate base, the
virus typically prevents the induction of an immune response and
thus manages to escape, yet vaccination against poxviruses has
been extremely successful (17). Apparently, once an adaptive im-
mune response has been triggered, the host is insensitive to the
viral immune evasive strategies. Our interpretation is that a qual-
itative memory identifies the VV epitopes as harmful, thereby cir-
cumventing the need for further innate instructions and enabling
the host to prevent secondary VV infections.
An immune system with qualitative memory has obvious ad-
vantages. The complex decision whether and how to react to spe-
cific epitopes need must be made only once. Memory lymphocytes
can thus prevent tissue damage by pathogens on reinfection and on
pathogen dissemination to other organs. There is, however, a draw-
back. Instructed lymphocytes, that are fairly independent of further
innate instructions run the risk of mounting inappropriate cross-
reactive immune responses. For example, self-reactive lympho-
cytes that have escaped self tolerance induction may become stim-
ulated by a pathogen and subsequently become aggressive towards
self (31, 32). Additionally, memory lymphocytes may cross-react
in response to subsequent pathogens (33–35) and induce a memory
response of the wrong mode, e.g., Th1 instead of Th2. The immune
system should therefore be specific enough to avoid such cross-
reactivity mistakes. On the other hand, the immune system should
be sufficiently cross-reactive to ensure an immune response against
any pathogen. Here we develop a model to calculate the optimal
degree of specificity of lymphocytes to fulfill both requirements.
Specificity of memory
To calculate the optimal specificity of lymphocytes, we will define
the probability Ps of surviving infection by any specific pathogen
and calculate for which degree of lymphocyte cross-reactivity this
probability is maximal. Let the degree of cross-reactivity of lym-
phocytes be called p, i.e., each clonotype has a chance p to respond
to a randomly selected epitope. In a naive animal, p corresponds to
a conventional precursor frequency. Species having evolved highly
specific clonotypes have a low p value, whereas those with cross-
reactive clonotypes have a high p value. For simplicity, the affinity
of clonotypes is not taken into account. A clonotype either re-
sponds to an epitope, if its affinity is higher than a certain threshold
affinity, or fails to respond.
Avoiding autoimmunity
To avoid autoimmunity, clonotypes responding to self epitopes
should be rendered tolerant, i.e., removed from the functional na-
ive repertoire. Consider an animal with R0 different lymphocyte
clones, and let f be the fraction of all self epitopes S that induce
self tolerance. The functional repertoire after tolerance induction R
consists of all clonotypes that do not respond to any of the fS
tolerizing self epitopes. Suppose the animal is infected by a patho-
gen, which for simplicity is represented by a single antigenic
epitope. The chance of mounting an immune response Pi is the
chance that at least one clone in the functional repertoire R will be
stimulated by the pathogen, i.e.,
Pi 5 12~1 2 p!R (1)
where the expected functional repertoire size
R 5 R0~12p! fS (2)
(see Refs. 36 and 37 for similar derivations).
Complete self tolerance induction
First consider the simple case that all of the animal’s self epitopes
induce tolerance; i.e., consider f 5 1. In Fig. 1a, the probability Pi
of making an immune response is plotted against the cross-reac-
tivity parameter p. If the immune system is very specific, there is
a large chance that none of the clones will recognize the pathogen.
On the other hand, if lymphocytes are very cross-reactive, self
tolerance induction impairs the immune system by reducing the
functional naive repertoire. The maximum value of Pi (Fig. 1a,
arrow) is attained for p ' 1/(fS) 5 1/S. The optimal specificity to
mount immune responses to foreign Ags thus reflects the number
of self epitopes that induce self tolerance. This result is identical
with the conclusion drawn from previous models (36, 38, 39),
namely, that immune systems are diverse primarily because ani-
mals have large numbers of self Ags.
Ignored self
Healthy animals, however, harbor potentially autoreactive lym-
phocytes that seem to be ignorant of their specific self ligands (40,
41) and may cause autoimmunity after stimulation (28, 29, 31, 32).
After infection by a pathogen, self tolerance is assured only if none
of the ignorant clonotypes is stimulated by cross-reactivities with
this pathogen. Let a denote the fraction of potentially autoreactive
clones in the functional repertoire, i.e., a is the fraction of clono-
types recognizing at least one ignored self epitope. Since only a
fraction p of this subset of clones will be stimulated by the patho-
gen, the fraction of truly autoaggressive clones in the functional
repertoire responding to a particular pathogenic epitope is pa. The
chance Pt of remaining self tolerant is the chance that none of the
clonotypes in the functional naive repertoire falls in this autoag-
gressive category. We are interested in the probability Ps that the
animal will survive the pathogenic attack, i.e., in the probability
that the animal will make an immune response and will remain
tolerant to the ignored self, i.e.,
3 Abbreviations used in this paper: LCMV, lymphocytic choriomeningitis virus; VV,
vaccinia virus.
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Ps 5 PtP~iut!5Pt 2 ~12p!R (3)
where P(iut) denotes the conditional probability of making an im-
mune response given that the animal remains tolerant, and
Pt 5 ~12pa!R (4)
and
a512~12p!~12f !S (5)
Note that the intuitive interpretation of Equation 3 is that the sur-
vival chance Ps is equal to the overall chance to stay tolerant minus
the chance to stay tolerant by making no immune response at all.
The fraction of self epitopes that is ignored is unknown, but
taking 20% as an example, the dashed line in Fig. 1c depicts the
probability Pt that the system will remain tolerant to all ignored
self epitopes when stimulated by a pathogen. This probability of
tolerance Pt appears to be roughly inversely related to the proba-
bility of immunity Pi (Fig. 1b, dashed line). This is because lym-
phocyte specificities that help epitope recognition, including self
epitopes, will thwart self tolerance. The survival chance Ps is de-
picted by the curve in Fig. 1d. The arrow in Fig. 1d shows that the
optimal lymphocyte specificity is much higher now than in the
case of complete self tolerance induction. Prevention of autoim-
munity to the ignored self apparently requires a high specificity
(see also Ref. 37).
If self tolerance induction is incomplete, the most important
parameter determining the optimal specificity is the number of
lymphocyte clones in the total repertoire R0: the more lymphocytes
are available, the more specific these lymphocytes should be (see
Fig. 2a). Highly specific lymphocytes reduce the chance of mount-
ing autoimmune responses and thus increase the survival chance of
the animal. Surprisingly, the number of self epitopes S, which
largely determines the optimal specificity under complete toler-
ance induction, hardly affects the optimal specificity if self toler-
ance induction is incomplete. Neither does the fraction of ignored
self epitopes (1 2 f), in that all curves for which f , 0.8 are very
similar to the f 5 0.8 curve.
In practice, selection for the optimal specificity might be hard to
accomplish. Once a specificity has been selected for that gives
sufficient protection against the typical total number of different
pathogens infecting a host (k), the driving force to evolve to an
even better specificity vanishes. It might therefore be more infor-
mative to consider the range of specificities for which Psk is suf-
ficiently large, say larger than 0.9. If an individual is exposed to
;100 different pathogens on average, this range Psk . 0.9 contains
all specificities for which P, . 0.9989 (denoted by the black bars
in Fig. 1, a and d, and the “error bars” in Fig. 2). The specificity
range for which Psk . 0.9 in the case of~complete self tolerance
induction overlaps with that of incomplete self tolerance and is
much wider. If self tolerance induction is complete, the optimal
specificity level is thus not defined as sharply as it is when some
epitopes fail to induce self tolerance, and more particularly it is not
as sharply defined as the 1/S value suggested previously (36). Sum-
marizing, repertoires that run the risk of mounting autoimmune
responses to ignored self epitopes should be orders of magnitude
more specific than repertoires that need only to respond to many
pathogens (cf. the recent paper by Mason (42)).
Avoiding responses of an inappropriate mode
A second problem of cross-reactivity is that memory lymphocytes
that have acquired a certain mode of immunity during a primary
immune reaction may respond to subsequent pathogens (33–35)
that require a different mode of response. Besides the widely ac-
cepted Th1 vs Th2 modes, many other modes of immunity may
exist, varying in the type of lymphocytes, effector mechanisms,
and cytokines involved (43, 44). It has been demonstrated exper-
imentally that the cytokine profile of a T cell response is deter-
mined by the cytokines present during lymphocyte activation (re-
viewed in Refs. 22 and 43) and is epigenetically transmitted from
mother to daughter lymphocyte (45, 46). Thus, by secreting cyto-
FIGURE 1. Avoiding autoimmunity. The chance
of mounting an immune response Pi (a and b), the
chance of remaining self tolerant Pt (c), and the
chance of surviving a pathogenic attack Ps (d), de-
fined by Equations 1–5, plotted against the cross-
reactivity p of lymphocytes. Specificity is simply
the inverse of cross-reactivity. Arrows show that
the optimal cross-reactivity in the case of complete
self tolerance induction (a) is much larger than the
optimal cross-reactivity when some self epitopes
fail to induce tolerance (d). The black bars in a and
d denote the specificity ranges for which the cor-
responding survival chances are close to the opti-
mum, i.e., for which Psk . 0.9989, with k 5 100
different pathogens infecting a host (see text for
further explanation). Parameters are S 5 105, R0 5
1010, and f 5 1 (a) or f 5 0.8 (b–d).
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kines, cross-reactive memory cells may provide a wrong context
for a primary immune response to be induced and can as a con-
sequence impair immunity to subsequent pathogens.
The avoidance of such wrong mode responses is another driving
force for the specificity of the adaptive immune system. Consider
again an animal with a functional lymphocyte repertoire of R
clonotypes (to exclude any effect of self-tolerance induction, Equa-
tion 2 is not yet substituted). The chance Ps(i) of surviving infec-
tion by the ith pathogen, i.e., the chance of making an immune
response without triggering any cross-reactive memory clono-
types, is now dependent on the fraction of memory clones in the
repertoire m, and consequently on the number of previous infec-
tions (i 2 1). Only a fraction p of all memory lymphocytes will
recognize the ith pathogen, so that the fraction of clonotypes cross-
reacting with the present and one previous infection is pm. The
chance Ps to survive k different pathogens is the product of all
survival chances from the first until the kth pathogen, i.e.,
Ps 5 P
i51
k
Ps~i! (6)
where, in analogy to Equations 3 and 4,
Ps~i!5~12pm!R 2 ~12p!R (7)
and
m 5 p~i 2 1! (8)
Remember that any memory clone of an animal that has survived
infection by (i 2 1) different pathogens can, by our definition, be
responsive to a single previous pathogen only.
In Fig. 3, the survival chance Ps is plotted for serial infection by
various numbers of pathogens k. Fig. 3 shows that the optimal
specificity changes drastically from p 5 1 (i.e., 100% cross-reac-
tivity), if the animal is exposed to only one pathogen, to a highly
specific optimum, in the case of more pathogens. Immunological
memory, and the accompanying risk of inducing inappropriate re-
sponses by cross-reactivity, thus forces the immune system to be
specific. Again, it is the repertoire size R, and not the number of
different pathogens k, that largely determines the optimal specific-
ity (Fig. 3).
Of mice and men
Because the optimal specificity to avoid cross-reactive immune
responses is largely dependent on the size of the lymphocyte rep-
ertoire, our model predicts that the human and the mouse lympho-
cyte systems may be quite different. To illustrate the predicted
differences, the two models of the previous section are combined.
The chance Ps(i) to survive infection by the ith pathogen is now the
chance that none of the responding clonotypes is either a memory
clone or a clone specific for an ignored self epitope, minus the
chance that no immune response is made at all, i.e.,
Ps~i!5~12p~m 1 a!!R 2 ~12p!R (9)
FIGURE 2. What determines the optimal specificity? The optimal
cross-reactivity plotted against the size of the total lymphocyte repertoire
R0 (a) or against the number of self epitopes S (b). If self tolerance induc-
tion is complete (f 5 1), the optimal cross-reactivity decreases as the num-
ber of self epitopes increases (b). The curves for which f 5 0.8 are typical
for all cases of incomplete self tolerance induction (f , 1). The optimal
specificity in the case of incomplete tolerance induction is thus hardly
dependent on the fraction of self epitopes that induces tolerance (f). Results
indicate that if self tolerance induction is incomplete, the optimal cross-
reactivity depends mainly on the size of the lymphocyte repertoire (a) and
is hardly dependent on the number of self epitopes (b).
FIGURE 3. Avoiding responses of an inappropriate mode. The chance
of surviving a single or multiple different pathogenic attacks, defined by
Equations 6–8, plotted against the cross-reactivity (p) of lymphocytes. The
curves denote the chances to survive infection by 1, 2, 10 and 100 patho-
gens, respectively. The optima of the latter three curves nearly coincide.
Thick arrow, optimum in the case of infection by a hundred pathogens.
Results indicate that if an animal is exposed to multiple different patho-
gens, and thus runs the risk of mounting cross-reactive immune responses,
clonotypes should be much more specific (thick arrow) than they should be
if immunity against a single pathogen were the only demand (thin arrow).
In the latter case, clonotypes should be maximally cross-reactive (p 5 1).
Parameters are R 5 1010, k 5 1 (z z z z z), k 5 2 (– – – –), k 5 10 (- - - - -),
and k 5 100 (——).
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where R is given by Equation 2, a by Equation 5, and m by Equa-
tion 8. The chance to survive k pathogens is still given by Equation
6. In Fig. 4, the chance of mounting 10 immune responses (Pi10,
dashed curves), and the chance of surviving (Ps, solid curves) after
serial exposure to 10 different pathogens (k 5 10) are plotted. The
total human lymphocyte repertoire is estimated to consist of 1011–
1012 T/B lymphocytes, whereas the mouse repertoire consists of
;108 lymphocytes (47, 48). Taking an average clone size of 10
lymphocytes/clone, we estimate the number of clonotypes in hu-
mans and mice to be 1010 and 107, respectively, i.e., a difference
of 3 orders of magnitude. Fig. 4 shows that at the optimum of the
survival curve, human lymphocytes are orders of magnitude more
specific than mouse lymphocytes. This is a new prediction. Previ-
ous models (36, 38, 39) have predicted that lymphocytes in mice
and humans should be equally specific, i.e., p ' 1/S (provided that
mice and humans have similar numbers of self epitopes).
The need to avoid cross-reactivity with ignored self molecules
and the avoidance of inappropriate cross-reactive memory re-
sponses are two independent driving forces for the specificity of
lymphocytes. For the current parameter setting, the optimal lym-
phocyte specificity is mainly determined by the need to avoid au-
toimmune responses. For other parameter settings, e.g., for a lower
number of self Ags S and a higher number of pathogens k with
which an animal is typically infected, it may be the avoidance of
inappropriate memory responses that determines the optimum of
the survival curve.
In the optimum, the number of different clones responding to a
pathogen is approximately the same for mice and humans. Thanks
to the high specificity of human clones, humans should run a lower
risk of mounting autoimmune responses than mice. The mouse
immune system must make a concession: whereas its protection
against infections could be just as good as that of humans (Fig. 4b,
thin arrow), the need to avoid inappropriate cross-reactive re-
sponses forces the mouse immune system to be more specific (Fig.
4b, thick arrow). Thus, its resistance against infections is some-
what reduced. Summarizing, mice are predicted to have a smaller
survival chance than humans because they suffer more from in-
fections and from autoimmunity.
Discussion
We have argued that the adaptive immune system specifically
stores the instructions given by the innate immune system and that
the specificity of lymphocytes is used largely for avoidance of
inappropriate cross-reactive immune responses (see also Ref. 49).
It has been suggested previously that the diversity of the immune
system reflects the number of self epitopes that induce tolerance
(36, 38, 39). Here, we have shown that if there is any risk of
inducing inappropriate cross-reactive immune responses, the im-
mune system needs to be much more specific than had been de-
rived from these previous models (36, 38, 39). In particular, mem-
ory lymphocytes should not be triggered by cross-reactive
stimulation by food or self Ags (50).
Intuitively, it is hard to see how responsiveness to foreign Ags
and avoidance of inappropriate immune responses can be recon-
ciled merely by selecting for a certain degree of lymphocyte spec-
ificity (42). In our framework, however, there is an asymmetry
between naive and memory clonotypes that allows this conflict to
be solved. Inappropriate immune responses come from memory
clonotypes only. In our model, naive clones do not run the risk of
inducing an inappropriate immune response, because they either
remain naive or are properly instructed to switch to the required
phenotype. It is this asymmetry that allows for a high optimum of
the survival curve at a high degree of lymphocyte specificity.
By considering the risk of cross-reactive autoimmune responses,
we have implicitly calculated the optimal specificity of memory
lymphocytes. Because naive lymphocytes do not run the risk of
inducing inappropriate responses, it might be beneficial to have
naive cells that are more cross-reactive than the memory cells.
Interestingly, naive B cells indeed appeared to react to a broader
range of Ags than did memory B cells (51) (see also Ref. 52 and
references therein). Because B cell hypermutation and affinity mat-
uration occur largely after the primary immune response (53, 54),
it is tempting to suggest that the function of B cell hypermutation
is to induce highly specific memory B cells, on top of inducing a
high affinity secondary response (see also Refs. 52 and 55, in
which a more general form of specificity maturation was suggest-
ed). This idea is supported by the observation that beyond a certain
avidity threshold there is no correlation between Ab avidity and
protection against infection (56, 57). Recent x-crystallographic
FIGURE 4. Of mice and men. Comparison of the optimal clonotype
specificity for humans (a) and mice (b) if both types of inappropriate cross-
reactive immune responses, i.e., autoimmunity towards the ignored self and
mode selection failure caused by cross-reactive, old memories, can occur.
The chance of surviving after infection by ten different pathogens (Ps,
defined by Equations 2, 5–6 and 8–9; ——), and the chance of mounting
immune responses against those 10 different pathogens (Pi10, defined by
Equations 1 and 2; . . . .), are plotted against the cross-reactivity p of
lymphocytes. Thick arrows, optimal cross-reactivity of mouse and human
lymphocytes. Human lymphocytes should be orders of magnitude more
specific than mouse lymphocytes. Thin arrow, optimal specificity of mice
clonotypes if resistance against many of pathogens were the only demand.
Parameters are S 5 105, f 5 0.8, k 5 10, and R0 5 1010 (for humans (a))
and R0 5 107 (for mice (b)).
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studies uncovered a possible mechanism for specificity maturation:
affinity-matured Abs are more specific because they have a more
rigid configuration than germline Abs (58). Selection for a high
affinity thus seems to imply selection for a high specificity. It has
been demonstrated that lymphocytes specific for self Ags are rou-
tinely generated during B cell somatic mutations (59). In combi-
nation with the strong selective pressure on recognition of the orig-
inal foreign Ag (60), specificity maturation may reduce the chance
of releasing lymphocytes with cross-reactivity for self Ags into the
periphery.
Throughout the calculations, the assumption was made that
stimulation of a single clone is sufficient for a functional immune
response. Obviously, this is a strong simplification. It is very likely
that protection against infection and induction of autoimmunity
require activation of multiple clones. We have chosen for maximal
simplicity, however, because the qualitative results of the model
do not depend on such complications. In their protecton theory,
Cohn and Langman (61) proposed that lymphocytes act in a con-
centration-dependent manner; to compensate for their larger lymph
volume, large animals would require more lymphocytes of the
same Ag specificity than small animals do. We can account for this
argument in our model by considering the expected repertoire size
per unit volume. All calculations would remain the same, and our
claim that immunological memory should be as specific as possi-
ble (per unit volume) remains true. It is only the predicted differ-
ence between large and small animals that disappears in the pro-
tecton version of our model. The protecton model need not be
correct, however. Because of lymphocyte recirculation and hom-
ing to the sites of infections, large animals may indeed profit from
their large lymphocyte repertoire. Even if this is only partly the
case, our model correctly predicts a specificity and survival dif-
ference between mice and humans.
The high optimal specificities that we calculate seem to be at
odds with recent measurements of precursor frequencies per-
formed with MHC/peptide tetramers (62, 63) and with other esti-
mates of lymphocyte cross-reactivity (42). It should be stressed,
however, that the optimal cross-reactivities calculated here reflect
precursor frequencies in naive animals, which experimentally re-
main “soft numbers” (63, 64). Naive precursor frequencies may be
orders of magnitude lower than the precursor frequencies reported
in MHC/peptide tetramer studies after immunization (62, 63).
Moreover, the precise quantitative results of our model depend on
the specific choice of parameters and simplifications made (see
also Ref. 37). For example, we disregarded any safeguards that
prevent cross-reactive cells from causing inappropriate immune
responses (23, 59). Additionally, there is no affinity in our model,
whereas experimental estimates of precursor frequencies depend
on the affinity cutoff of the specific assay that is used. Despite these
quantitative complications, however, our results show that the
need to avoid inappropriate immune responses imposes a strong
selection pressure for the specificity of lymphocytes. Importantly,
our model shows that the specificity constraints on lymphocytes
are even stronger than was concluded previously (36, 38, 39).
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